Global Antimicrobial Growth Promoters Market Growth 2024-2030

Global Antimicrobial Growth Promoters Market Growth 2024-2030

Product Code:792866

Published Date: Jan 02,2024

Pages: 106

Region: Global

Category: Chemical & Material

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

According to our LPI (LP Information) latest study, the global Antimicrobial Growth Promoters market size was valued at US$ 1097.6 million in 2023. With growing demand in downstream market, the Antimicrobial Growth Promoters is forecast to a readjusted size of US$ 1574.6 million by 2030 with a CAGR of 5.3% during review period. 
The research report highlights the growth potential of the global Antimicrobial Growth Promoters market. Antimicrobial Growth Promoters are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antimicrobial Growth Promoters. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antimicrobial Growth Promoters market.

Antimicrobial growth promoters (AGPs) are antibiotics added to the feed of food animals to enhance their growth rate and production performance. The mechanism by which AGPs work is not clear. AGPs reduce normal intestinal flora (which compete with the host for nutrients) and harmful gut bacteria (which may reduce performance by causing subclinical disease). The effect on growth may be due to a combination of both fewer normal intestinal flora and fewer harmful bacteria
There has been a developing controversy surrounding the use of antibiotics as growth promoters for food animals. These drugs are used at low doses in animal feeds and are considered to improve the quality of the product, with a lower percentage of fat and a higher protein content in the meat. Other benefits of the use of antibiotic growth-promoters include control of zoonotic pathogens such as Salmonella, Campylobacter, Escherichia coli and enterococci. Use of any antibiotic is associated with the selection of resistance in pathogenic bacteria and it has been argued that the use of antibiotic growth-promoters imposes a selection pressure for bacteria that are resistant to antibiotics that may be used in clinical or veterinary practice, thus compromising the continued use of antimicrobial chemotherapy.

Key Features:
The report on Antimicrobial Growth Promoters market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Antimicrobial Growth Promoters market. It may include historical data, market segmentation by Type (e.g., Penicillins, Incosamides), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antimicrobial Growth Promoters market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Antimicrobial Growth Promoters market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Antimicrobial Growth Promoters industry. This include advancements in Antimicrobial Growth Promoters technology, Antimicrobial Growth Promoters new entrants, Antimicrobial Growth Promoters new investment, and other innovations that are shaping the future of Antimicrobial Growth Promoters.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antimicrobial Growth Promoters market. It includes factors influencing customer ' purchasing decisions, preferences for Antimicrobial Growth Promoters product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antimicrobial Growth Promoters market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antimicrobial Growth Promoters market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antimicrobial Growth Promoters market. 
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antimicrobial Growth Promoters industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antimicrobial Growth Promoters market.

Market Segmentation:
Antimicrobial Growth Promoters market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
    Penicillins
    Incosamides
    Macrolides
    Others

Segmentation by application
    Animal Feed
    Therapeutic Antimicrobial Drugs
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Cargill
    Royal DSM
    Zoetis
    Alltech
    Elanco Animal Health
    Merck Animal Health
    Bayer Animal Health
    Biomin Holding
    Boehringer Ingelheim
    Bupo Animal Health
    Danisco
    Novus International
    Vetoquinol

Key Questions Addressed in this Report
What is the 10-year outlook for the global Antimicrobial Growth Promoters market?
What factors are driving Antimicrobial Growth Promoters market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antimicrobial Growth Promoters market opportunities vary by end market size?
How does Antimicrobial Growth Promoters break out type, application?